Related Experiment Videos
Interferon enhanced natural killer function in Hodgkin's disease.
Nouvelle Revue Francaise D'Hematologie
|January 1, 1986
Summary
Natural killer (NK) cell activity is reduced in Hodgkin's disease patients. Interferon partially restored NK cell function, but some patients showed limited response, suggesting complex underlying mechanisms.
Area of Science:
- Immunology
- Oncology
Background:
- Hodgkin's disease is a cancer of the lymphatic system.
- Natural killer (NK) cells play a crucial role in immune surveillance against cancer.
Purpose of the Study:
- To evaluate NK cell activity in patients with active Hodgkin's disease.
- To investigate the effect of interferon on NK cell function in these patients.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from 19 Hodgkin's disease patients and 22 healthy controls were analyzed.
- NK cell activity was measured using K562 target cells in a 4-hour assay.
- PBMCs were preincubated with recombinant interferon alpha.
Main Results:
- Patients with active Hodgkin's disease exhibited significantly decreased NK cell activity compared to healthy individuals (P < 0.01).
- Interferon treatment significantly enhanced NK cell function in patients (P < 0.001).
- However, 4 patients remained below the normal range, and some showed poor response to interferon.
Conclusions:
- NK cell activity is impaired in active Hodgkin's disease.
- Interferon can partially restore NK cell function but may not fully overcome the deficits in all patients.
- The mechanisms underlying depressed NK cell activity in Hodgkin's disease are complex and not entirely responsive to interferon.